Master Screening and Reassessment Protocol (MSRP) for the NCI MyeloMATCH Clinical Trials

This study is designed to test blood and bone marrow samples to help doctors find the best treatments for certain blood and bone marrow cancers, like acute myeloid leukemia. By looking for specific biological markers, the study aims to match patients with the most appropriate clinical trials or standard care pathways.

Adults who are 18 or older and are suspected of having untreated acute myeloid leukemia or myelodysplastic syndrome may be eligible to join. Participants generally must not have received prior cancer treatments for these specific conditions, though some exceptions apply.

Participants will undergo testing, including blood draws and bone marrow samples, to check for genetic and cellular markers. Based on these results, doctors will guide you toward targeted treatment studies or standard medical care options.

This study is currently recruiting participants at multiple locations across the United States, including sites in Alabama and Arizona.